152 related articles for article (PubMed ID: 6665766)
1. Dipyridamole inhibits platelet aggregation in whole blood.
Gresele P; Zoja C; Deckmyn H; Arnout J; Vermylen J; Verstraete M
Thromb Haemost; 1983 Dec; 50(4):852-6. PubMed ID: 6665766
[TBL] [Abstract][Full Text] [Related]
2. Dipyridamole potentiates the inhibition of platelet aggregation by aspirin (in human platelet rich plasma and whole blood).
Violi F; Praticò D; Iuliano L; Balsano F
J Lipid Mediat; 1991; 4(1):61-7. PubMed ID: 1909906
[TBL] [Abstract][Full Text] [Related]
3. [Inhibition of induced thrombocyte aggregation in the presence of endothelial cells by dipyridamole].
Kirchmaier CM; Altorjay J; Bellinger O; Breddin HK
Vasa Suppl; 1991; 32():318-21. PubMed ID: 1771524
[TBL] [Abstract][Full Text] [Related]
4. Dipyridamole potentiates platelet inhibition by nitric oxide.
Bult H; Fret HR; Jordaens FH; Herman AG
Thromb Haemost; 1991 Sep; 66(3):343-9. PubMed ID: 1746006
[TBL] [Abstract][Full Text] [Related]
5. Significance of plasma adenosine in the antiplatelet activity of forskolin: potentiation by dipyridamole and dilazep.
Agarwal KC; Zielinski BA; Maitra RS
Thromb Haemost; 1989 Feb; 61(1):106-10. PubMed ID: 2749584
[TBL] [Abstract][Full Text] [Related]
6. Effect of 1-methyl-2-mercapto-5-(3-pyridyl)-imidazole (KC-6141) on rabbit platelet aggregation in vitro and rat platelet retention.
Umetsu T; Kato T
Thromb Haemost; 1978 Feb; 39(1):167-76. PubMed ID: 580491
[TBL] [Abstract][Full Text] [Related]
7. Papaverine inhibits human platelet aggregation induced by ADP.
Serro-Azul MI; Bydlowski SP; Chamone DA
Braz J Med Biol Res; 1992; 25(5):521-8. PubMed ID: 1342229
[TBL] [Abstract][Full Text] [Related]
8. The effects of dopamine on human platelet aggregation, in vitro.
Braunstein KM; Sarji KE; Kleinfelder J; Schraibman HB; Colwell JA; Eurenius K
J Pharmacol Exp Ther; 1977 Feb; 200(2):449-57. PubMed ID: 839449
[TBL] [Abstract][Full Text] [Related]
9. The in vitro effect of amrinone on platelet aggregation in human whole blood.
Pattison A; Eason CT; Bonner FW
Res Commun Chem Pathol Pharmacol; 1986 Feb; 51(2):261-4. PubMed ID: 3083485
[TBL] [Abstract][Full Text] [Related]
10. Estimation of anti-platelet drugs on human platelet aggregation with a novel whole blood aggregometer by a screen filtration pressure method.
Sudo T; Ito H; Ozeki Y; Kimura Y
Br J Pharmacol; 2001 Aug; 133(8):1396-404. PubMed ID: 11498527
[TBL] [Abstract][Full Text] [Related]
11. Dipyridamole inhibits red cell-induced platelet activation.
Saniabadi AR; Tomiak RH; Lowe GD; Barbenel JC; Forbes CD
Atherosclerosis; 1989 Apr; 76(2-3):149-54. PubMed ID: 2730712
[TBL] [Abstract][Full Text] [Related]
12. Effects of dilazep (AS-05) on human blood platelet aggregation.
Kuzuya F
Arzneimittelforschung; 1979; 29(3):539-42. PubMed ID: 582740
[TBL] [Abstract][Full Text] [Related]
13. Effect of dipyridamole alone and in combination with aspirin on whole blood platelet aggregation, PGI2 generation, and red cell deformability ex vivo in man.
Saniabadi AR; Fisher TC; McLaren M; Belch JF; Forbes CD
Cardiovasc Res; 1991 Mar; 25(3):177-83. PubMed ID: 2029709
[TBL] [Abstract][Full Text] [Related]
14. [The effect of low-dose acetylsalicylic acid on platelet aggregation parameters in vitro].
Cardona M; Escolar G; Roig E; Bastida E; Ordinas A; Sanz G
Rev Esp Cardiol; 1992 Apr; 45(4):264-9. PubMed ID: 1598464
[TBL] [Abstract][Full Text] [Related]
15. Potentiation of the antiplatelet action of adenosine in whole blood by dipyridamole or dilazep and the cAMP phosphodiesterase inhibitor, RA 233.
Dawicki DD; Agarwal KC; Parks RE
Thromb Res; 1986 Jul; 43(2):161-75. PubMed ID: 3016942
[TBL] [Abstract][Full Text] [Related]
16. The association of platelet and red cell count with platelet impedance changes in whole blood and light-scattering changes in platelet rich plasma: evidence from the Caerphilly Collaborative Heart Disease Study.
Sharp DS; Beswick AD; O'Brien JR; Renaud S; Yarnell JW; Elwood PC
Thromb Haemost; 1990 Oct; 64(2):211-5. PubMed ID: 2270530
[TBL] [Abstract][Full Text] [Related]
17. [Disorders of haemostasis in patients undergoing maintenance haemodialysis, with special reference to recurrent arteriovenous fistula thrombosis. Effects of dipyridamole (author's transl)].
Jacques C; Drueke T; Nedellec J; Kremp O; Gazengel C
Pathol Biol (Paris); 1976 Dec; 24 Suppl():27-32. PubMed ID: 827731
[TBL] [Abstract][Full Text] [Related]
18. The synergistic effect of aspirin and dipyridamole upon platelet thrombi in living blood vessels.
Honour AJ; Hockaday TD; Mann JI
Br J Exp Pathol; 1977 Jun; 58(3):268-72. PubMed ID: 871376
[TBL] [Abstract][Full Text] [Related]
19. [Inhibitory activity of bencyclan on platelet aggregation in vitro and in vivo (author's transl)].
Jäger W; Scharrer I; Satkowski U; Breddin K
Arzneimittelforschung; 1975; 25(12):1938-44. PubMed ID: 1243666
[TBL] [Abstract][Full Text] [Related]
20. Effect of xanthinol nicotinate treatment on platelet aggregation.
Seidel G; Endell W
Int J Clin Pharmacol Biopharm; 1977 Mar; 15(3):139-43. PubMed ID: 844933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
